Press Releases Year None20202019201820172016 Gamida Cell Announces Appointment of David Fox to Its Board of Directors July 7, 2020 PDF Version View HTML Gamida Cell to Present at the JMP Securities Virtual Hematology and Oncology Forum June 12, 2020 PDF Version View HTML Gamida Cell Announces Full Exercise of Underwriters’ Option to Purchase Additional Shares May 26, 2020 PDF Version View HTML Gamida Cell Reports First Quarter 2020 Financial Results and Provides Company Update May 21, 2020 PDF Version View HTML Gamida Cell Announces Pricing of $60 Million Public Offering of Ordinary Shares May 18, 2020 PDF Version View HTML Gamida Cell Announces Launch of Proposed Public Offering of Ordinary Shares May 18, 2020 PDF Version View HTML Gamida Cell Announces the Date of Its First Quarter 2020 Financial Results and Webcast May 18, 2020 PDF Version View HTML Gamida Cell Announces Positive Topline Data from Phase 3 Clinical Study of Omidubicel in Patients with High-Risk Hematologic Malignancies May 12, 2020 PDF Version View HTML Gamida Cell Announces Updated Data from Phase 1 Study of GDA-201 to be Presented at the Annual Meeting of the European Society for Blood and Marrow Transplantation March 2, 2020 PDF Version View HTML Gamida Cell Reports Full Year 2019 Financial Results and Provides Company Update February 25, 2020 PDF Version View HTML Pagination Current page 1 Page 2 Next page next › Last page last » Displaying 1 - 10 of 13
